The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
22-Nov-06
$NA
Target:
CABB GmbH
Acquiror:
AXA Private Equity
Advised Gilde Buy Out Partners on the sale of CABB, a leading producer of monochloroacetic acid and related specialty intermediates, to AXA Private Equity
10-Nov-06
$1.9 billion
Target:
John Laing plc
Acquiror:
Henderson Equity Partners
Advised John Laing plc, the leading UK infrastructure investor and developer, on a recommended cash offer
06-Nov-06
$4.2 billion
Target:
Kos Pharmaceuticals, Inc.
Acquiror:
Abbott Laboratories
Advised Kos Pharmaceuticals, Inc., a specialty pharmaceutical provider of cardiovascular and respiratory drugs, on its sale to Abbott Laboratories
11-Oct-06
$NA
Target:
Visa USA
Advised Visa USA in its announced plans to merge with Visa Canada and Visa International to form Visa Inc., a new public global corporation
03-Oct-06
$445 million
Target:
Tele2 AB’s fixed telephony and broadband business in France
Acquiror:
SFR S.A.
Advised SFR S.A., the second largest mobile telecoms operator in France on the acquisition of the French fixed telephony and broadband business of Tele2 AB